Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function.

Area of Science:

• Epigenetics and Cardiovascular Disease
• Molecular Biology
• Genomics

Background:

• DNA hypomethylation at the F2RL3 locus is linked to smoking and cardiovascular disease.
• F2RL3 encodes protease-activated receptor 4, crucial for platelet activation.
• The pathway from smoking-induced F2RL3 alterations to myocardial infarction remains unclear.

Purpose of the Study:

• To investigate if smoking-induced F2RL3 DNA hypomethylation mediates myocardial infarction risk through platelet reactivity.
• To explore the biological mechanisms linking smoking, F2RL3 methylation, and cardiovascular disease.

Main Methods:

• Analysis of cohort data (N=3205) on smoking, F2RL3 methylation, and myocardial infarction.
• Comparison of platelet reactivity in individuals with low vs. high F2RL3 methylation (N=41).
• In vitro studies using cigarette smoke extract and reporter assays to assess F2RL3 gene expression and methylation.

Main Results:

• F2RL3 DNA methylation explained 34% of the smoking effect on myocardial infarction risk.
• Lower F2RL3 methylation correlated with altered platelet reactivity.
• Cigarette smoke extract reduced F2RL3 methylation and increased F2RL3 mRNA levels.

Conclusions:

• Smoking-induced F2RL3 hypomethylation may increase PAR4 expression, impacting platelet reactivity and contributing to cardiovascular disease risk.
• F2RL3 DNA methylation represents a potential pathway linking smoking to myocardial infarction.
• Further research into F2RL3 regulation could reveal novel therapeutic targets.